IP Library › Granted Patent US 12,630,547
Granted Patent B2
US 12,630,547 · App. 17/753,686 · Granted May 19, 2026

RAS protein degraders, pharmaceutical compositions thereof, and their therapeutic applications

Inventors: Kyle W.H. Chan (San Diego, CA); Aparajita Hoskote Chourasia (San Diego, CA); Paul E. Erdman (San Diego, CA); Leah M. Fung (San Diego, CA); David Aaron Hecht (Chula Vista, CA); Imelda Lam (San Diego, CA); Frank Mercurio (Rancho Santa Fe, CA); Robert W. Sullivan (Vista, CA); Eduardo Torres (San Diego, CA)
Assignee: BioTheryX, Inc.
C07D471/04A61P11/00A61P35/00C07D401/14C07D405/14C07D417/14C07D471/14C07D495/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,630,547
App. No.
17/753,686
Granted
May 19, 2026
Kind
B2
Abstract

Provided herein are RAS protein degraders, e.g., a compound of Formula (I), and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a RAS-mediated disorder, disease, or condition. R Het - L 2 -X- L 1 -R 1   (1)

Claims (209)

1 . A compound of Formula (I):

R Het - L 2 -X- L 1 -R 1   (I)

or an enantiomer, a mixture of enantiomers, a diastereomer, a mixture of two or more diastereomers, a tautomer, a mixture of two or more tautomers, or an isotopic variant thereof; or

a pharmaceutically acceptable salt, solvate, or hydrate thereof; wherein:

R 1 is

R Het is

X is C 1 -C 15 alkylene, heteroalkylene, C 2 -C 10 alkenylene, C 2 -C 10 alkynylene, phenylene, five to six membered heteroarylene, five to six membered heterocyclylene, or C 3 -C 8 cycloalkylene, each of which is optionally substituted with one or more R 18 ; or X is C 1 -C 15 alkylene, heteroalkylene, C 2 -C 10 alkenylene, or C 2 -C 10 alkynylene, wherein one or more methylene repeating units is replaced by a ring structure, each ring structure independently selected from the group consisting of phenylene, five to six membered heteroarylene, five to six membered heterocyclylene, and C 3 -C 8 cycloalkylene, and wherein each ring structure is independently and optionally substituted with one or more R 18 ;

L 1 is

or a bond;

L 2 is a bond, —O—, —S—, —NR 16a —, —(CH 2 ) 1-3 —, —C(═O)—, or —(CH 2 ) 0-3 C(═O) NR 16a —;

each of Q 1 , Q 2 , and Q 3 is independently S or CH, provided that one of Q 1 , Q 2 , and Q 3 is S;

Q is CH 2 or C(O);

n is an integer of 0, 1, or 2;

each R A is independently deuterium, hydroxyl, halogen, cyano, nitro, optionally substituted C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, optionally substituted amino, C 1 -C 6 alkylamino, (amino) C 1 -C 6 alkyl, —(C═O) NR 17a R 17b , (C 1 -C 6 alkoxy) C 1 -C 6 alkyl, —O—(C 1 -C 6 alkoxy) C 1 -C 6 alkyl, or optionally substituted C 3 -C 7 cycloalkyl;

R 2 is H, deuterium, halogen, or C 1 -C 6 alkyl;

each R 3 is independently H, deuterium, C 1 -C 6 alkyl,

each R 4 is independently H, C 1 -C 6 alkyl, —C(O) C 1 -C 6 alkyl, —C(O) C 2 -C 6 alkenyl, —C(O) C 3 -C 8 cycloalkyl, —C(O) (C 3 -C 8 cycloalkyl) C 1 -C 6 alkyl, —C(O)— (3 to 7 membered heteroaryl), —C(O)-(3 to 7 membered heterocyclyl), —C(O)-(3 to 7 membered heterocyclyl) C 1 -C 6 alkyl, —C(O) NR 17a R 17b , —S(O) 2 C 1 -C 6 alkyl, —S(O) 2 C 2 -C 6 alkenyl, —S(O) 2 C 3 -C 8 cycloalkyl, —S(O) 2 (C 3 -C 8 cycloalkyl) C 1 -C 6 alkyl, —S(O) 2 -(3 to 7 membered heterocyclyl), —S(O) 2 -(3 to 7 membered heterocyclyl) C 1 -C 6 alkyl, or —S(O) 2 NR 17a R 17b , wherein, when R 4 is not H, R 4 is optionally substituted with one or more R 18 ;

each of R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , and R 15 is independently halogen, hydroxyl, cyano, nitro, optionally substituted C 1 -C 6 alkyl, optionally substituted C 1 -C 6 haloalkyl, optionally substituted C 1 -C 6 alkoxy, optionally substituted C 1 -C 6 haloalkoxy, optionally substituted amino, (C 1 -C 6 alkoxy) C 1 -C 6 alkyl, —O—(C 1 -C 6 alkoxy) C 1 -C 6 alkyl, or optionally substituted C 3 -C 7 cycloalkyl;

each of R 16 , R 16a , and R 16b is independently H or C 1 -C 6 alkyl;

each R 17a and R 17b is independently H or C 1 -C 6 alkyl; or R 17a and R 17b together with the nitrogen atom to which they are attached form 5 or 6 membered heterocyclyl, each optionally substituted with one or more R 18 ;

each R 18 is independently C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, (C 1 -C 6 alkoxy) C 1 -C 6 alkyl, —O—(C 1 -C 6 alkoxy) C 1 -C 6 alkyl, optionally substituted amino, halogen, or cyano; or two geminal R 18 form oxo;

each of R 19a and R 19b is independently H, optionally substituted C 1 -C 6 alkyl, optionally substituted C 2 -C 6 alkenyl, optionally substituted C 2 -C 6 alkynyl, optionally substituted C 6 -C 10 aryl, optionally substituted 5 to 10 membered heteroaryl, optionally substituted C 7 -C 14 aralkyl, optionally substituted 3 to 10 membered heterocyclyl, or optionally substituted C 3 -C 8 carbocyclyl;

each of R 20a and R 20b is independently H, halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, or C 3 -C 8 carbocyclyl;

each of R 21a and R 21b is independently H, optionally substituted C 1 -C 6 alkyl, optionally substituted C 6 -C 10 aryl, optionally substituted C 7 -C 14 aralkyl, or optionally substituted C 3 -C 8 carbocyclyl;

each of s1, s2, s3, s4, s5, s6, s7, s8, s9, s10, and s11 is independently an integer of 0, 1, 2 or 3;

each of Y 1 , Y 2 , and Y 3 is independently N or CH;

each Z 1 is independently a bond, —(CR a R b ) q1 —, —C(═O)—, —CH═CH—, or —C≡C—;

each Z 2 is independently-(CR c R d ) q2 —;

each of Z 3 and Z 4 is independently NR 16 , O, S, or a bond;

each of R a , R b , R c , and R d is independently H, halogen, hydroxyl, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, or optionally substituted C 3 -C 6 cycloalkyl;

q1 and q2 are each independently an integer of 1, 2, or 3;

each of X 1 and X 2 is independently O or S;

each ring A is independently phenylene, five to six membered heteroarylene, five to six membered heterocyclylene, or C 3 -C 8 cycloalkylene, each of which is optionally substituted with one or more R 18 ; and

each of m1, m2, m3, m4, m5, m6, m7, m8, m9, k1, k2, k3, k4, k5, k6, k7, k8, and k9 is independently an integer of 0, 1, 2, 3, 4, or 5.

2 . The compound of claim 1 , wherein R 1 is

3 . The compound of claim 1 , wherein R Het is

4 . The compound of claim 1 , having the structure of Formula (III):

or an enantiomer, a mixture of enantiomers, a diastereomer, a mixture of two or more diastereomers, a tautomer, a mixture of two or more tautomers, or an isotopic variant thereof; or

a pharmaceutically acceptable salt, solvate, or thereof; wherein:

R 5a , R 5b , and R 5c are each independently H or R 5 ;

R 6a is H or R 6 ; and

R 7a and R 7b are each independently H or R 7 .

5 . The compound of claim 4 , having the structure of Formula (XVI):

or an enantiomer, a mixture of enantiomers, a diastereomer, a mixture of two or more diastereomers, a tautomer, a mixture of two or more tautomers, or an isotopic variant thereof; or

a pharmaceutically acceptable salt, solvate, or hydrate thereof.

6 . The compound of claim 4 , having the structure of Formula (XVIII):

or an enantiomer, a mixture of enantiomers, a diastereomer, a mixture of two or more diastereomers, a tautomer, a mixture of two or more tautomers, or an isotopic variant thereof; or

a pharmaceutically acceptable salt, solvate, or hydrate thereof.

7 . The compound of claim 6 , having the structure of Formula (XIX):

or an enantiomer, a mixture of enantiomers, a diastereomer, a mixture of two or more diastereomers, a tautomer, a mixture of two or more tautomers, or an isotopic variant thereof; or

a pharmaceutically acceptable salt, solvate, or hydrate thereof.

8 . The compound of claim 4 , having the structure of Formula (XX):

or an enantiomer, a mixture of enantiomers, a diastereomer, a mixture of two or more diastereomers, a tautomer, a mixture of two or more tautomers, or an isotopic variant thereof; or

a pharmaceutically acceptable salt, solvate, or hydrate thereof.

9 . The compound of claim 1 , wherein R 2 is H.

10 . The compound of claim 1 , wherein R 3 is H.

11 . The compound of claim 1 , wherein Q is CH 2 .

12 . The compound of claim 1 , wherein Q is C(O).

13 . The compound of claim 4 , wherein R 5a is H, optionally substituted C 1 -C 6 alkoxy, or optionally substituted amino; or wherein R 5a is H, 2-dimethylamino-ethoxy, (S)-1-methylpyrrolidin-2-ylmethoxy, or 2-dimethylcarbamoylethylamino.

14 . The compound of claim 4 , wherein R 5b is halogen; or wherein R 5b is fluoro or chloro.

15 . The compound of claim 4 , wherein R 5c is H or halogen; or wherein R 5c is H, fluoro, or chloro.

16 . The compound of claim 4 , wherein R 6a is halogen or fluoro.

17 . The compound of claim 4 , wherein R 7a is H or optionally substituted C 1 -C 6 alkyl; or wherein R 7a is H, methyl, or cyanomethyl.

18 . The compound of claim 4 , wherein R 7b is H or optionally substituted C 1 -C 6 alkyl; or wherein R 7b is H or methyl.

19 . The compound of claim 1 , having the structure of Formula (XXV):

or an enantiomer, a mixture of enantiomers, a diastereomer, a mixture of two or more diastereomers, a tautomer, a mixture of two or more tautomers, or an isotopic variant thereof; or

a pharmaceutically acceptable salt, solvate, or hydrate thereof.

20 . The compound of claim 1 , having the structure of Formula (XXVII):

or an enantiomer, a mixture of enantiomers, a diastereomer, a mixture of two or more diastereomers, a tautomer, a mixture of two or more tautomers, or an isotopic variant thereof; or

a pharmaceutically acceptable salt, solvate, or hydrate thereof.

21 . The compound of claim 1 , wherein R 1 is

22 . The compound of claim 1 , wherein L 1 is a bond,

or wherein L 1 is a bond, —NH—, pyrrolidin-1,3-diyl, piperidin-1,3-diyl, piperidin-1,4-diyl,

23 . The compound of claim 1 , wherein L 2 is a bond or O.

24 . The compound of claim 1 , wherein X is C 1 -C 15 alkylene or heteroalkylene; or wherein X is C 1 -C 15 alkylene or heteroalkylene, where one or more methylene repeating units is replaced by a ring structure, each ring structure independently selected from the group consisting of phenylene, five to six membered heteroarylene, five to six membered heterocyclylene, and C 3 -C 8 cycloalkylene.

25 . The compound of claim 1 , wherein X is pentan-1,5-diyl, hexan-1,6-diyl, heptan-1,7-diyl, octan-1,8-diyl, nonan-1,9-diyl, decan-1,10-diyl, undecan-1,11-diyl, piperazin-1,4-diyl,

26 . A compound selected from:

3-(2-(2-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluoro-phenoxy) ethoxy) ethoxy)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-ethyl) propanamide 1;

3-(2-(2-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluoro-phenoxy) ethoxy) ethoxy)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-ethyl) propanamide 3;

3-(2-(2-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluoro-phenoxy) ethoxy) ethoxy)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-ethyl) propanamide 6;

3-(2-(2-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluoro-phenoxy) ethoxy) ethoxy)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-ethyl) propanamide 8;

4-((2-(2-(2-(2-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) ethoxy) ethoxy) ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl) isoindoline-1,3-dione 9;

3-(4-(1-(8-(2-(8-chloro-6-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) octyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 20;

4-((2-(2-(2-(2-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) ethoxy) ethoxy) ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl) isoindoline-1,3-dione 23;

(3S)-3-(1-((4-(((7-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) heptyl)amino)methyl) phenoxy)methyl)-4-oxo-4H-thieno[3,4-c]pyrrol-5 (6H)-yl)-piperidine-2,6-dione 24;

(3S)-3-(1-((4-(((7-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) heptyl)amino)methyl) phenoxy)methyl)-4-oxo-4H-thieno[3,4-c]pyrrol-5 (6H)-yl) piperidine-2,6-dione 25;

1-(7-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluoro-phenoxy) heptyl)-3-((5-(2,6-dioxopiperidin-3-yl)-4-oxo-5,6-dihydro-4H-thieno[3,4-c]pyrrol-1-yl)methyl) urea 27;

1-(7-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluoro-phenoxy) heptyl)-3-((5-(2,6-dioxopiperidin-3-yl)-4-oxo-5,6-dihydro-4H-thieno[3,4-c]pyrrol-1-yl)methyl) urea 28;

3-(2-(2-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluoro-phenoxy) ethoxy) ethoxy)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)amino) ethyl)-propanamide 29;

3-(2-(2-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluoro-phenoxy) ethoxy) ethoxy)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)amino) ethyl)-propanamide 30;

4-((2-(2-(2-(2-(2-(4-(4-acetylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) ethoxy) ethoxy) ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl) isoindoline-1,3-dione 31;

4-(6-chloro-7-(2-(2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-amino) ethoxy) ethoxy) ethoxy) ethoxy)-6-fluorophenyl)-8-fluoroquinazolin-4-yl) piperazine-1-carboxamide 32;

4-((8-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluoro-phenoxy) octyl)amino)-2-(2,6-dioxopiperidin-3-yl) isoindoline-1,3-dione 33;

4-((8-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluoro-phenoxy) octyl)amino)-2-(2,6-dioxopiperidin-3-yl) isoindoline-1,3-dione 34;

3-(4-(1-(7-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluoro-phenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 36;

3-(4-(1-(7-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 37;

3-(2-(2-(3-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-4-fluoro-phenoxy) ethoxy) ethoxy)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)amino)-ethyl) propanamide 38;

3-(2-(2-((R)-3-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-4-fluorophenoxy) ethoxy) ethoxy)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)amino)-ethyl) propanamide 39;

3-(4-(1-(7-(2-(4-(4-(1H-imidazole-5-carbonyl) piperazin-1-yl)-6-chloro-8-fluoro-quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl)-piperidine-2,6-dione 41;

4-((2-(2-(2-(2-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) ethoxy) ethoxy) ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl) isoindoline-1,3-dione 42;

3-(4-(1-(7-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 43;

3-(4-(1-(8-((R)-2-(8-chloro-6-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) octyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 49;

3-(4-(1-(7-(2-(6-chloro-4-(4-(cyclopentanecarbonyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 51;

3-(4-(1-(7-(2-(6-chloro-8-fluoro-4-(4-(tetrahydro-2H-pyran-4-carbonyl) piperazin-1-yl)-quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl)-piperidine-2,6-dione 52;

3-(4-(1-(7-(2-(6-chloro-4-(4-(2-cyclopropylacetyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 53;

3-(4-(1-(7-(2-(6-chloro-8-fluoro-4-(4-(tetrahydrofuran-3-carbonyl) piperazin-1-yl)-quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl)-piperidine-2,6-dione 54;

4-((2-(2-(2-(2-((4-((2S,5R)-4-acryloyl-2,5-dimethylpiperazin-1-yl)-6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl) quinazolin-2-yl)oxy) ethoxy) ethoxy) ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl) isoindoline-1,3-dione 58;

3-(4-(1-(7-(2-(6-chloro-4-(4-(ethylsulfonyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 59;

3-(4-(1-(5-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) pentyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 60;

3-(4-(1-(9-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) nonyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 61;

(3S)-3-(4-((4-(((3-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) propyl)amino)methyl)benzyl)oxy)-1-oxoisoindolin-2-yl) piperidine-2,6-dione 62;

(3S)-3-(4-((4-(((3-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) propyl)amino)methyl)benzyl)oxy)-1-oxoisoindolin-2-yl) piperidine-2,6-dione 63;

3-(1-(1-(7-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluoro-phenoxy) heptyl) piperidin-4-yl)-4-oxo-4H-thieno[3,4-c]pyrrol-5 (6H)-yl) piperidine-2,6-dione 70;

3-(1-(1-(7-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-4-oxo-4H-thieno[3,4-c]pyrrol-5 (6H)-yl) piperidine-2,6-dione 71;

3-(4-(1-(7-(2-(6-chloro-8-fluoro-4-(4-(pyrrolidine-3-carbonyl) piperazin-1-yl)-quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl)-piperidine-2,6-dione 79;

(E)-2-(4-(6-chloro-7-(2-((7-(4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1-oxoisoindolin-4-yl) piperidin-1-yl) heptyl)oxy)-6-fluorophenyl)-8-fluoroquinazolin-4-yl) piperazine-1-carbonyl)-4-methylpent-2-enenitrile 80;

3-(4-(1-(7-(2-(6-chloro-8-fluoro-4-(4-(oxetane-3-carbonyl) piperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 81;

3-(4-(1-(7-(2-(6-chloro-8-fluoro-4-(4-(2-fluoroacryloyl) piperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 82;

4-(6-chloro-7-(2-((7-(4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1-oxoisoindolin-4-yl)-piperidin-1-yl) heptyl)oxy)-6-fluorophenyl)-8-fluoroquinazolin-4-yl) piperazine-1-carboxamide 83;

3-(4-(1-(2-(4-(2-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy)ethyl)cyclohexyl)ethyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 84;

3-(4-(1-(7-(2-(6-chloro-8-fluoro-4-((S)-2-methyl-4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 85;

3-((6-chloro-7-(2-((7-(4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1-oxoisoindolin-4-yl)-piperidin-1-yl) heptyl)oxy)-6-fluorophenyl)-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-2-yl)amino)-N,N-dimethylpropanamide 86;

3-(4-(1-(7-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-3-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 87;

3-(4-(1-(7-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoro-2-(((S)-1-methyl-pyrrolidin-2-yl) methoxy) quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 88;

3-(4-(1-(7-(2-(6-chloro-8-fluoro-2-(((S)-1-methylpyrrolidin-2-yl) methoxy)-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 89;

3-(4-(1-(7-(3-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-4-fluoro-phenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 90;

3-(4-(1-(7-(3-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-4-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 91;

3-(4-(1-(2-(4-(2-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy)ethyl)-1H-1,2,3-triazol-1-yl)ethyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl)-piperidine-2,6-dione 92;

3-(5-(1-(7-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 93;

3-(5-(1-(7-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluoro-phenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 94;

(Z)-3-(4-(1-(7-(2-(6-chloro-4-(4-(2-chlorobut-2-enoyl) piperazin-1-yl)-8-fluoro-quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl)-piperidine-2,6-dione 96;

(Z)-3-(4-(1-(7-(2-(6-chloro-4-(4-(2-chloro-4-methylpent-2-enoyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl)-piperidine-2,6-dione 97;

(Z)-3-(4-(1-(7-(2-(6-chloro-4-(4-(2-chloropent-2-enoyl) piperazin-1-yl)-8-fluoro-quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl)-piperidine-2,6-dione 98;

3-(4-(1-(7-(2-(4-(4-acetylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluoro-phenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 99;

3-(4-(1-(2-((4-((2-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoro-quinazolin-7-yl)-3-fluorophenoxy) ethoxy)methyl)benzyl)oxy) ethyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 101;

2-((2S)-4-(6-chloro-7-(2-((7-(4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1-oxoisoindolin-4-yl) piperidin-1-yl) heptyl)oxy)-6-fluorophenyl)-8-fluoroquinazolin-4-yl)-1-(2-chloroacryloyl)-piperazin-2-yl) acetonitrile 102;

3-(4-(1-(5-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) pentyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 103;

3-(4-(1-(7-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-1-oxoisoindolin-2-yl) piperidine-2,6-dione 105;

3-(4-(1-(7-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-3-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 106;

3-(5-(1-(7-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 107;

3-(4-(1-(7-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoro-2-(((S)-1-methylpyrrolidin-2-yl) methoxy) quinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 108;

3-(4-(1-(2-((4-((2-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) ethoxy)methyl)benzyl)oxy) ethyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 109;

3-(4-(1-(2-(4-(2-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoro-quinazolin-7-yl)-3-fluorophenoxy)ethyl)cyclohexyl)ethyl) piperidin-4-yl)-6-fluoro-1-oxo-isoindolin-2-yl) piperidine-2,6-dione 110;

3-(4-(1-(4-(2-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy)ethyl) phenethyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 111;

3-(4-(1-(7-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) heptyl) pyrrolidin-3-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 112;

3-(4-(1-(9-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) nonyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 113;

3-(4-(1-(11-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) undecyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 114;

3-(4-(1-(7-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-2-(2-(dimethylamino)-ethoxy)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxo-isoindolin-2-yl) piperidine-2,6-dione 115;

3-(4-(1-(2-(4-(2-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoro-quinazolin-7-yl)-3-fluorophenoxy)ethyl)cyclohexyl)ethyl) piperidin-4-yl)-6-fluoro-1-oxo-isoindolin-2-yl) piperidine-2,6-dione 116;

3-(4-(1-(((1r,4r)-4-((2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoro-quinazolin-7-yl)-3-fluorophenoxy)methyl)cyclohexyl)methyl) piperidin-4-yl)-6-fluoro-1-oxo-isoindolin-2-yl) piperidine-2,6-dione 117;

3-(4-(1-((4-(2-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy)ethyl)cyclohexyl)methyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl)-piperidine-2,6-dione 118;

3-(5-(1-(7-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) heptyl) piperidin-3-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 119;

3-(4-(1-(2-(1-(2-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoro-quinazolin-7-yl)-3-fluorophenoxy)ethyl) piperidin-4-yl)ethyl) piperidin-4-yl)-6-fluoro-1-oxo-isoindolin-2-yl) piperidine-2,6-dione 120;

3-(4-(1-(3-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) propyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 121;

2-((2R)-4-(6-chloro-7-(2-((7-(4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1-oxoisoindolin-5-yl) piperidin-1-yl) heptyl)oxy)-6-fluorophenyl)-8-fluoroquinazolin-4-yl)-1-(2-chloroacryloyl)-piperazin-2-yl) acetonitrile 123;

3-(4-(1-(((1s,4s)-4-((2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoro-quinazolin-7-yl)-3-fluorophenoxy)methyl)cyclohexyl)methyl) piperidin-4-yl)-6-fluoro-1-oxo-isoindolin-2-yl) piperidine-2,6-dione 127;

2-((2R)-4-(6-chloro-7-(2-((7-(4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1-oxoisoindolin-4-yl) piperidin-1-yl) heptyl)oxy)-6-fluorophenyl)-8-fluoro-2-(((S)-1-methylpyrrolidin-2-yl)-methoxy) quinazolin-4-yl)-1-(2-chloroacryloyl) piperazin-2-yl) acetonitrile 128;

2-((2R)-4-(6-chloro-7-(2-(2-(4-(2-(4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1-oxo-isoindolin-4-yl) piperidin-1-yl)ethyl)cyclohexyl) ethoxy)-6-fluorophenyl)-8-fluoroquinazolin-4-yl)-1-(2-chloroacryloyl) piperazin-2-yl) acetonitrile 129;

3-(4-(1-(2-(3-(2-(2-(6-chloro-4-(4-(2-chloroacryloyl) piperazin-1-yl)-8-fluoro-quinazolin-7-yl)-3-fluorophenoxy)ethyl)cyclopentyl)ethyl) piperidin-4-yl)-6-fluoro-1-oxo-isoindolin-2-yl) piperidine-2,6-dione 130;

2-((2R)-4-(6-chloro-7-(2-(4-(2-(4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1-oxo-isoindolin-4-yl) piperidin-1-yl)ethyl) phenethoxy)-6-fluorophenyl)-8-fluoroquinazolin-4-yl)-1-(2-chloroacryloyl) piperazin-2-yl) acetonitrile 131;

2-((2R)-4-(6-chloro-7-(2-((7-(4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1-oxoisoindolin-5-yl) piperidin-1-yl) heptyl)oxy)-6-fluorophenyl)-8-fluoro-2-(((S)-1-methylpyrrolidin-2-yl)-methoxy) quinazolin-4-yl)-1-(2-chloroacryloyl) piperazin-2-yl) acetonitrile 132;

3-(4-((1-((2-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy)ethyl)glycyl) piperidin-4-yl)-125-ethynyl)-1-oxoisoindolin-2-yl) piperidine-2,6-dione 133;

(2S,4R)-1-((2S)-2-(7-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) heptanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl) pyrrolidine-2-carboxamide 50;

(2S,4R)-1-((2S)-2-(11-(2-(4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoroquinazolin-7-yl)-3-fluorophenoxy) undecanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl) pyrrolidine-2-carboxamide 76;

(2S,4R)-1-((2S)-2-(11-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) undecanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl) pyrrolidine-2-carboxamide 77;

(2S,4R)-1-((2S)-2-(7-(2-(6-chloro-8-fluoro-4-(4-propionylpiperazin-1-yl) quinazolin-7-yl)-3-fluorophenoxy) heptanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl) pyrrolidine-2-carboxamide 78;

2-(4-acryloyl-1-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl) quinazolin-4-yl)-piperazin-2-yl)-N-(5-(3-((5-(2,6-dioxopiperidin-3-yl)-6-oxo-5,6-dihydro-4H-thieno[2,3-c]pyrrol-2-yl)methyl) ureido) pentyl) acetamide 13;

4-((2-(2-(2-(2-(3-(1-acryloylazetidin-3-yl)-7-(3-hydroxynaphthalen-1-yl)-2-oxo-3,4-dihydroquinazolin-1 (2H)-yl) ethoxy) ethoxy) ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)-isoindoline-1,3-dione 2;

3-(1-((4-(((2-(7-(3-hydroxynaphthalen-1-yl)-2-oxo-3-(1-propionylazetidin-3-yl)-3,4-dihydroquinazolin-1 (2H)-yl)ethyl)amino) methyl) phenoxy)methyl)-4-oxo-4H-thieno[3,4-c]-pyrrol-5 (6H)-yl) piperidine-2,6-dione 4;

3-(1-((4-(((2-(2-(7-(3-hydroxynaphthalen-1-yl)-2-oxo-3-(1-propionylazetidin-3-yl)-3,4-dihydroquinazolin-1 (2H)-yl) ethoxy)ethyl)amino) methyl) phenoxy)methyl)-4-oxo-4H-thieno[3,4-c]pyrrol-5 (6H)-yl) piperidine-2,6-dione 5;

N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)ethyl)-3-(2-(2-(7-(3-hydroxynaphthalen-1-yl)-2-oxo-3-(1-propionylazetidin-3-yl)-3,4-dihydroquinazolin-1 (2H)-yl)-ethoxy) ethoxy) propanamide 7;

3-(2-(3-(1-acryloylazetidin-3-yl)-7-(3-hydroxynaphthalen-1-yl)-2-oxo-3,4-dihydro-quinazolin-1 (2H)-yl) ethoxy)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-ethyl) propanamide 10;

3-(2-(2-(3-(1-acryloylazetidin-3-yl)-7-(3-hydroxynaphthalen-1-yl)-2-oxo-3,4-dihydro-quinazolin-1 (2H)-yl) ethoxy) ethoxy)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)ethyl) propanamide 11;

2-(2,6-dioxopiperidin-3-yl)-4-((2-(2-(2-(2-(7-(3-hydroxynaphthalen-1-yl)-2-oxo-3-(1-propionylazetidin-3-yl)-3,4-dihydroquinazolin-1 (2H)-yl) ethoxy) ethoxy) ethoxy)ethyl)amino)-isoindoline-1,3-dione 12;

(S)-3-(1-((4-(((4-(3-(1-acryloylazetidin-3-yl)-7-(3-hydroxynaphthalen-1-yl)-2-oxo-3,4-dihydroquinazolin-1 (2H)-yl)butyl)amino) methyl) phenoxy)methyl)-4-oxo-4H-thieno[3,4-c]-pyrrol-5 (6H)-yl) piperidine-2,6-dione 16;

3-(1-((4-(((4-(3-(1-acryloylazetidin-3-yl)-7-(3-hydroxynaphthalen-1-yl)-2-oxo-3,4-dihydroquinazolin-1 (2H)-yl)butyl)amino) methyl) phenoxy)methyl)-4-oxo-4H-thieno[3,4-c]-pyrrol-5 (6H)-yl) piperidine-2,6-dione 19;

(S)-3-(1-((4-(((2-(7-(3-hydroxynaphthalen-1-yl)-2-oxo-3-(1-propionylazetidin-3-yl)-3,4-dihydroquinazolin-1 (2H)-yl)ethyl)amino) methyl) phenoxy)methyl)-4-oxo-4H-thieno[3,4-c]-pyrrol-5 (6H)-yl) piperidine-2,6-dione 22;

N-(7-(4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1-oxoisoindolin-4-yl) piperidin-1-yl)-heptyl)-2-(7-(3-hydroxynaphthalen-1-yl)-2-oxo-3-(1-propionylazetidin-3-yl)-3,4-dihydro-quinazolin-1 (2H)-yl) acetamide 35;

5-((2-(2-(2-(2-(3-(1-acryloylazetidin-3-yl)-7-(3-hydroxynaphthalen-1-yl)-2-oxo-3,4-dihydroquinazolin-1 (2H)-yl) ethoxy) ethoxy) ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)-isoindoline-1,3-dione 40;

3-(6-fluoro-4-(1-(7-(7-(3-hydroxynaphthalen-1-yl)-2-oxo-3-(1-propionylazetidin-3-yl)-3,4-dihydroquinazolin-1 (2H)-yl) heptyl) piperidin-4-yl)-1-oxoisoindolin-2-yl) piperidine-2,6-dione 44;

4-((2-(2-(2-(3-(1-acryloylazetidin-3-yl)-7-(3-hydroxynaphthalen-1-yl)-2-oxo-3,4-dihydro-quinazolin-1 (2H)-yl) ethoxy) ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)-isoindoline-1,3-dione 45;

3-(6-fluoro-4-(1-(7-((2-(7-(3-hydroxynaphthalen-1-yl)-2-oxo-3-(1-propionylazetidin-3-yl)-3,4-dihydroquinazolin-1 (2H)-yl)ethyl)amino) heptyl) piperidin-4-yl)-1-oxoisoindolin-2-yl)-piperidine-2,6-dione 46;

(S)-3-(1-((4-(((2-(2-(2-(2-(1-acryloylazetidin-3-yl)-6-(3-hydroxynaphthalen-1-yl)-4-oxoquinazolin-3 (4H)-yl) ethoxy) ethoxy)ethyl)amino) methyl) phenoxy)methyl)-4-oxo-4H-thieno[3,4-c]pyrrol-5 (6H)-yl) piperidine-2,6-dione 14;

(S)-3-(1-((4-(((2-(2-(1-acryloylazetidin-3-yl)-6-(3-hydroxynaphthalen-1-yl)-4-oxo-quinazolin-3 (4H)-yl)ethyl)amino) methyl) phenoxy)methyl)-4-oxo-4H-thieno[3,4-c]pyrrol-5 (6H)-yl) piperidine-2,6-dione 15;

2-(2-(1-acryloylazetidin-3-yl)-6-(3-hydroxynaphthalen-1-yl)-4-oxoquinazolin-3 (4H)-yl)-N-(2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino) ethoxy) ethoxy)-ethoxy)-ethyl) acetamide 17;

3-(1-((4-(((2-(2-(1-acryloylazetidin-3-yl)-6-(3-hydroxynaphthalen-1-yl)-4-oxo-quinazolin-3 (4H)-yl)ethyl)amino) methyl) phenoxy)methyl)-4-oxo-4H-thieno[3,4-c]pyrrol-5 (6H)-yl) piperidine-2,6-dione 18;

3-(1-((4-(((2-(2-(2-(1-acryloylazetidin-3-yl)-6-(3-hydroxynaphthalen-1-yl)-4-oxo-quinazolin-3 (4H)-yl) ethoxy)ethyl)amino) methyl) phenoxy)methyl)-4-oxo-4H-thieno[3,4-c]-pyrrol-5 (6H)-yl) piperidine-2,6-dione 21;

3-(1-((4-(((2-(2-(6-(3-hydroxynaphthalen-1-yl)-4-oxo-2-(1-propionylazetidin-3-yl)-quinazolin-3 (4H)-yl) ethoxy)ethyl)amino) methyl) phenoxy)methyl)-4-oxo-4H-thieno[3,4-c]-pyrrol-5 (6H)-yl) piperidine-2,6-dione 26;

4-((2-(2-(2-(2-((4-((R)-4-acryloyl-3-methylpiperazin-1-yl)-7-(naphthalen-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)oxy) ethoxy) ethoxy) ethoxy)ethyl)amino)-2-(2,6-dioxo-piperidin-3-yl) isoindoline-1,3-dione 47;

2-(2,6-dioxopiperidin-3-yl)-4-((2-(2-(2-(2-((4-((R)-3-methyl-4-propionylpiperazin-1-yl)-7-(naphthalen-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)oxy) ethoxy) ethoxy) ethoxy)-ethyl)amino) isoindoline-1,3-dione 48;

3-(4-(1-(7-((4-(4-acryloylpiperazin-1-yl)-7-(3-hydroxynaphthalen-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)oxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 75;

3-(4-(1-(7-(2-(4-((S)-4-acryloyl-2-methylpiperazin-1-yl)-6-fluoro-1-(2-isopropyl-phenyl)-2-oxo-1,2-dihydropyrido[2,3-d]pyrimidin-7-yl)-3-fluorophenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 72;

3-(6-fluoro-4-(1-(7-(3-fluoro-2-(6-fluoro-1-(2-isopropylphenyl)-4-((S)-2-methyl-4-propionylpiperazin-1-yl)-2-oxo-1,2-dihydropyrido[2,3-d]pyrimidin-7-yl) phenoxy) heptyl)-piperidin-4-yl)-1-oxoisoindolin-2-yl) piperidine-2,6-dione 73;

3-(4-(1-(7-(2-(4-((S)-4-(2-chloroacryloyl)-2-methylpiperazin-1-yl)-6-fluoro-1-(2-isopropylphenyl)-2-oxo-1,2-dihydropyrido[2,3-d]pyrimidin-7-yl)-3-fluorophenoxy) heptyl)-piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 100;

3-(4-(1-(7-(2-(4-((S)-4-(2-chloroacryloyl)-2-methylpiperazin-1-yl)-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-d]pyrimidin-7-yl)-3-fluoro-phenoxy) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 122;

3-(4-(1-(7-(2-(4-((S)-4-acryloyl-2-methylpiperazin-1-yl)-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-d]pyrimidin-7-yl)-3-fluorophenoxy) heptyl)-piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 124;

3-(4-(1-(7-(4-(4-((S)-4-(2-Chloroacryloyl)-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-2-oxopyrido[2,3-d]pyrimidin-1 (2H)-yl)-3-isopropylphenyl) heptyl)-piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 126;

3-(4-(1-(7-(2-((2R,4aR)-3-acryloyl-11-chloro-9-fluoro-2,6-dimethyl-5-oxo-2,3,4,4a,5,6-hexahydro-1H-pyrazino[1′,2′: 4,5]pyrazino[2,3-c]quinolin-10-yl)-3-fluorophenoxy) heptyl)-piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 64;

3-(4-(1-(7-(2-((2R,4aR)-11-chloro-9-fluoro-2,6-dimethyl-5-oxo-3-propionyl-2,3,4,4a,5,6-hexahydro-1H-pyrazino[1′,2′: 4,5]pyrazino[2,3-c]quinolin-10-yl)-3-fluorophenoxy)-heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 65;

3-(4-(1-(7-(2-((2R,4aR)-11-chloro-3-(2-chloroacryloyl)-9-fluoro-2,6-dimethyl-5-oxo-2,3,4,4a,5,6-hexahydro-1H-pyrazino[11,2′: 4,5]pyrazino[2,3-c]quinolin-10-yl)-3-fluorophenoxy)-heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 104;

3-(4-(1-(7-((2R,4aR)-3-acryloyl-11-chloro-9-fluoro-10-(2-fluoro-6-hydroxyphenyl)-2-methyl-5-oxo-1,2,3,4,4a,5-hexahydro-6H-pyrazino[1′,2′: 4,5]pyrazino[2,3-c]quinolin-6-yl)-heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 66;

3-(4-(1-(7-((2R,4aR)-11-chloro-9-fluoro-10-(2-fluoro-6-hydroxyphenyl)-2-methyl-5-oxo-3-propionyl-1,2,3,4,4a,5-hexahydro-6H-pyrazino[1′,2′: 4,5]pyrazino[2,3-c]quinolin-6-yl)-heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 67;

2-((2R,4aR)-11-chloro-6-(7-(4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1-oxoisoindolin-4-yl) piperidin-1-yl) heptyl)-9-fluoro-2-methyl-5-oxo-3-propionyl-2,3,4,4a,5,6-hexahydro-1H-pyrazino[1′,2′: 4,5]pyrazino[2,3-c]quinolin-10-yl)-3-fluorophenyl propionate 95; or

3-(4-(1-(7-((2R,4aR)-11-chloro-3-(2-chloroacryloyl)-9-fluoro-10-(2-fluoro-6-hydroxy-phenyl)-2-methyl-5-oxo-1,2,3,4,4a,5-hexahydro-6H-pyrazino[1′,2′: 4,5]pyrazino[2,3-c]quinolin-6-yl) heptyl) piperidin-4-yl)-6-fluoro-1-oxoisoindolin-2-yl) piperidine-2,6-dione 125;

or an enantiomer, a mixture of enantiomers, a diastereomer, a mixture of two or more diastereomers, a tautomer, a mixture of two or more tautomers, or an isotopic variant thereof; or

a pharmaceutically acceptable salt, solvate, or hydrate thereof.

27 . A pharmaceutical composition comprising a compound of claim 1 , and a pharmaceutically acceptable excipient.

28 . A method of inhibiting the activity of RAS in a biological sample, comprising contacting one or more cells in the biological sample with an effective amount of a compound of claim 1 .

29 . A method of treating or ameliorating a disease, disorder, or condition associated with a RAS, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of claim 1 .

Continuity (3)
Provisional Application 62941599 · Nov 27, 2019
Provisional Application 62900249 · Sep 13, 2019
Related Publication 20230002371A1 · Jan 5, 2023
References Cited (35)
US 20180015087A1 · Liu · 2018 [cited by examiner]
US 20180170948A1 · Chan · 2018 [cited by examiner]
US 20190315732A1 · Crew et al. · 2019 [cited by applicant]
US 20200109149A1 · Wang et al. · 2020 [cited by applicant]
CN 101805390A · 2010 [cited by applicant]
WO 2018006801A1 · 2018 [cited by applicant]
WO 2018006804A1 · 2018 [cited by applicant]
WO WO2018068017A1 · 2018 [cited by examiner]
WO WO2018140514A1 · 2018 [cited by examiner]
WO WO2019195609A2 · 2019 [cited by examiner]
Bondeson et al., Annu Rev Pharmacol Toxicol, 2017, 57:107-123 (Year: 2017). [cited by examiner]
Pettersson et al., Drug Discov Today Technol, 2019, 31:15-27 (Year: 2019). [cited by examiner]
Cyrus et al., Chem Med Chem, 2010, 5:979-985 (Year: 2010). [cited by examiner]
Berge et al., “Pharmaceutical salts,” J. Pharm. Sci. 1977, 66, 1-19. [cited by applicant]
Cox et al., “Drugging the undruggable RAS: Mission possible?” Nat. Rev. Drug Discov. 2014, 13, 828-51. [cited by applicant]
Fang et al., “Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives,” Acta Pharm. Sin. B 2020, 10, 1253-78. [cited by applicant]
Janes et al., “Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor,” Cell 2018, 172, 578-89. [cited by applicant]
Milburn et al., “Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins,” Science 1990, 247, 939-45. [cited by applicant]
Papke and Der, “Drugging RAS: Know the enemy,” Science 2017, 355, 1158-63. [cited by applicant]
Rebocho and Marais, “New insight puts CRAF in sight as a therapeutic target,” Cancer Discov. 2011, 1, 98-9. [cited by applicant]
Santana-Codina et al., “Defining and targeting adaptations to oncogenic Kras G12C inhibition using quantitative temporal proteomics,” Cell Rep. 2020, 30, 4584-99. [cited by applicant]
Simanshu et al., “RAS proteins and their regulators in human disease,” Cell 2017, 170, 17-33. [cited by applicant]
Uras et al., “, Targeting KRAS mutant non-small-cell lung cancer: past, present and future,” Int. J. Mol. Sci. 2020, 21, 4325. [cited by applicant]
Wang et al., “Degradation of proteins by PROTACs and other strategies,” Acta Pharm. Sin. B 2020, 10, 207-38. [cited by applicant]
Zeng et al., “Exploring targeted degradation strategy for oncogenic KRAS G12C,” Cell Chem. Biol. 2020, 27, 19-31. [cited by applicant]
Chen et al., “SAR study of celastrol analogs targeting Nur77-mediated inflammatory pathway,” Eur. J. Med. Chem. 2019, 177, 171-87. [cited by applicant]
Cho et al., “Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways,” Cancer Res. 2007, 67, 674-83. [cited by applicant]
Lee et al., “The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53,” Oncogene 2012, 31, 3265-76. [cited by applicant]
Pearen and Muscat, “Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease,” Mol. Endocrinol. 2010, 24, 1891-903. [cited by applicant]
Safe et al., “Minireview: role of orphan nuclear receptors in cancer and potential as drug targets,” Mol. Endocrinol. 2014, 28, 157-72. [cited by applicant]
Wang et al., “Orphan nuclear receptor Nur77 promotes colorectal cancer invasion and metastasis by regulating MMP-9 and E-cadherin,” Carcinogenesis 2014, 35, 2474-84. [cited by applicant]
Wu and Chen, “Characteristics of Nur77 and its ligands as potential anticancer compounds (Review),” Mol. Med. Rep. 2018, 18, 4793-801. [cited by applicant]
Zhang, “Targeting Nur77 translocation,” Expert Opin. Ther. Targets 2007, 11, 69-79. [cited by applicant]
Zheng et al., “Orphan nuclear receptor TR3/Nur77 is a specific therapeutic target for hepatic cancers,” J. Clin. Exp. Oncol. 2017, 6, 184. [cited by applicant]
Zhou et al., “Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling,” Nat. Commun. 2014, 5, 3388. [cited by applicant]